Latest News
Vertex Pharmaceuticals Incorporated
- Form 4 Vertex Pharmaceuticals Inc: Daniel J. Brennan (Director) For: 20 October
- Vertex Pharmaceuticals (VRTX) Q1 2026 Earnings Call Transcript
- Vertex Pharmaceuticals Inc Stock (VRTX) Moved Down by 3.13% on Oct 13: What Investors Need To Know
- Amgen vs. Vertex Pharmaceuticals: Which Biotech Stock Is a Better Buy in 2026?
- Vertex Pharmaceuticals Inc Stock (VRTX) Moved Down by 3.21% on Oct 1: What Investors Need To Know
- M&A slows in Q3 but Vertex snags one of the year’s biggest in $10B Crinetics buy
- 2 Wall Street Analysts Think Vertex Pharmaceuticals Stock Can Soar Another 20% or More Over the Next 12 Months. Here's Why They're Right.
- Vertex Pharmaceuticals- Still Too Much Emphasis On CF Supremacy - I Foresee A Downgrade
- CRISPR Therapeutics vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?
Headlines from the last 30 days, linking to the original publishers. See all market news →